BU Lead Enzyme Therapies, Germany
Quick Summary
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.Guided by our purpose to develop medicines that make a profound impact on people’s lives,
Who We Are
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.
Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.
About Commercial
Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.
The Business Unit Lead works across three organisations: leading the local German Enzyme Therapies team, partnering with the Global Enzyme Therapies Business Unit on brand strategy, lifecycle, and indication expansion, and aligning with the regional EUCAN Enzyme Therapies organisation on subregional brand plans, market access, and best-practice sharing. Success requires strategic agility, business acumen, people leadership, and the ability to work collaboratively across a matrix organisation.
- Define and execute the commercial strategy for the Enzyme Therapies franchise in Germany, translating global and EUCAN brand strategy into a localised plan that delivers revenue and patient-access goals.
- Lead, coach, and develop the German Enzyme Therapies team; build capability, set ambitious but achievable targets, and manage performance.
- Own the German Enzyme Therapies budget; develop sales plans aligned to revenue goals and available resources, and manage spend with clear direction.
- Partner with the Global Enzyme Therapies BU on brand planning, competitive positioning, and lifecycle priorities; bring the German market perspective into global forums.
- Align with regional EUCAN Enzyme Therapies leadership on subregional brand plans, market access strategy, and cross-country knowledge sharing.
- Drive cross-functional collaboration with Market Access, Medical Affairs, Marketing, Patient Advocacy, and Commercial Operations to ensure coordinated execution.
- Spend time in the field with customers and KOLs, gathering insight and acting as the “voice of the customer” back into brand and regional teams.
- Build and maintain strong relationships with key opinion leaders, treating centers, and the patient community.
- Ensure all activities are conducted in full compliance with BioMarin policies, local regulations, and industry codes, role-modelling the highest standards of ethics and integrity.
Experience & Qualifications
- Significant pharmaceutical/biotech commercial experience (5+ years), including field sales management and leadership of teams.
- Proven track record in rare disease, specialty, or innovative medicines; experience in lysosomal diseases, paediatrics, endocrinology, or related therapeutic areas is a strong advantage.
- Demonstrated people-leadership and management expertise; hiring, building, developing, and motivating commercial teams.
- Strong business acumen and budget ownership; results-oriented with a sense of urgency and the judgment to adjust when goals are not met.
- Ability to operate effectively in a matrix environment, influencing and gaining cooperation without direct authority.
- Comfortable in an entrepreneurial, lean commercial environment, with an understanding of the constraints of a focused rare-disease organisation.
- Excellent communication and presentation skills; able to build credibility with KOLs, payers, and internal stakeholders.
- Deep commitment to compliance and to patient advocacy on behalf of the metabolic diseases community.
- Fluent German and English (written and spoken).
- Willingness to travel.
Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.
Equal Opportunity Employer/Veterans/Disabled
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Location & Eligibility
Listing Details
- Posted
- June 16, 2026
- First seen
- June 18, 2026
- Last seen
- June 18, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 52%
- Scored at
- June 18, 2026
Signal breakdown
Please let biomarin know you found this job on Jobera.
3 other jobs at biomarin
View all →Explore open roles at biomarin.
Similar Lead jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.